the Ministry of Science, Innovation and Universities, Spain (Grants RYC-2014-15581, AGL2016-81890-REDT, AGL2017-88329-R and FJCI-2017-31689)
It's important to note that this treatment must be administered and monitored by a healthcare professional experienced in allergy and hormone disorders to ensure safety and effectiveness, especially if performed during pregnancy
This approach prioritizes your safety and optimal results, though it may affect your total investment
Our U.S.-based team is available to assist with product information, documentation requests, and order-related questions
For queries, complaints, or support, please contact [email protected]